Ascentage Pharma Group International
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-06-30 | 2023-12-31 | 2023-06-30 |
|---|---|---|---|---|
Cash | 1,236,578 | 1,100,314 | 1,069,296 | 1,581,600 |
Basic Shares | 315,224 | 314,654 | 290,196 | 289,808 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $980,650 | $221,984 | $209,711 | $27,910 |
Gross Profit | 951,565 | 191,441 | 187,713 | 24,582 |
Net Income | -405,433 | -925,637 | -882,924 | -782,424 |
Net Change In Cash | 980,650 | 221,984 | 209,711 | 27,910 |
Free Cash Flow | -135,646 | -782,921 | -890,878 | -1,041,308 |
Cash | 1,236,578 | 1,069,296 | 1,475,639 | 1,706,886 |
Basic Shares | 315,224 | 290,196 | 265,185 | 262,880 |
